Pembrolizumab for previously treated, microsatellite instability–high/mismatch repair–deficient advanced colorectal cancer: final analysis of KEYNOTE-164
European Journal of Cancer · 2023
DOI: 10.1016/j.ejca.2023.02.016 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2023. Verfasst von Dung T Le und 19 weiteren Autor:innen. Beteiligte Einrichtung: Oncology, Sidney Kimmel Comprehensive Cancer Center at John Hopkins University, Baltimore, MD, USA. Electronic address: dle@jhmi.edu. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Colonic Neoplasms. Die Arbeit wurde bisher 99-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Merck Sharp and Dohme.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Oncology, Sidney Kimmel Comprehensive Cancer Center at John Hopkins University, Baltimore, MD, USA. Electronic address: dle@jhmi.edu.
- Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Oncology, Asan Medical Center, Seoul, Republic of Korea.
- Oncology, Asan Medical Center, Seoul, Republic of Korea; University of Ulsan, Ulsan, Republic of Korea.
- Digestive Oncology, University Hospitals Gasthuisberg, Leuven and KU Leuven, Leuven, Belgium.
- Oncology Division, Tel Aviv Sourasky Medical Center, Tel Aviv-Yafo, Israel.
- Medical Oncology, University Medical Center Heidelberg, National Center for Tumor Diseases, Heidelberg, Germany.
Förderung
- Merck Sharp and Dohme
Zitieren
APA
Le, D. T., Diaz, L. A., Kim, T. W., Van Cutsem, E., Geva, R., Jäger, D., Hara, H., Burge, M., O'Neil, B. H., Kavan, P., Yoshino, T., Guimbaud, R., Taniguchi, H., Élez, E., Al-Batran, S. E., Boland, P. M., Cui, Y., Leconte, P., Marinello, P., & André, T. (2023). Pembrolizumab for previously treated, microsatellite instability–high/mismatch repair–deficient advanced colorectal cancer: final analysis of KEYNOTE-164. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2023.02.016
Vancouver
Le DT, Diaz LA, Kim TW, Van Cutsem E, Geva R, Jäger D, et al. Pembrolizumab for previously treated, microsatellite instability–high/mismatch repair–deficient advanced colorectal cancer: final analysis of KEYNOTE-164. European Journal of Cancer. 2023. doi:10.1016/j.ejca.2023.02.016
BibTeX
@article{Le2023,
author = {Le, Dung T and Diaz, Luis A and Kim, Tae Won and Van Cutsem, Eric and Geva, Ravit and Jäger, Dirk and Hara, Hiroki and Burge, Matthew and O'Neil, Bert H and Kavan, Petr and Yoshino, Takayuki and Guimbaud, Rosine and Taniguchi, Hiroya and Élez, Elena and Al-Batran, Salah-Eddin and Boland, Patrick M and Cui, Yi and Leconte, Pierre and Marinello, Patricia and André, Thierry},
title = {Pembrolizumab for previously treated, microsatellite instability–high/mismatch repair–deficient advanced colorectal cancer: final analysis of KEYNOTE-164},
journal = {European Journal of Cancer},
year = {2023},
doi = {10.1016/j.ejca.2023.02.016}
}
EUVIMED